Tirzepatide has emerged as a groundbreaking treatment for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its supply have become key topics for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its costly nature presents a wholesale peptide supplier significa